Variable | Nonrecurrence (n = 81) | Recurrence (n = 16) | P |
---|---|---|---|
Preoperatively available data | |||
AFP level (ng/mL) | 15.03 ± 21.60 | 19.02 ± 28.85 | 0.526 |
Pre-LT treatment | 0.721 | ||
Yes | 68 | 14 | |
No | 13 | 2 | |
Tumors detected on MRI | |||
Numbers | < 0.001 | ||
No viable tumor | 60 | 5 | |
Within UCSF criteria | 21 | 11 | |
Largest tumor size (cm) | 2.83 ± 1.48 | 3.15 ± 1.77 | 0.596 |
Quantitative indices | |||
DWIT/L | 1.31 ± 0.36 | 1.56 ± 0.41 | 0.093 |
ADCmean (× 10− 3 mm2/s) | 1.50 ± 0.27 | 1.32 ± 0.30 | 0.111 |
ADCmin (× 10−3 mm2/s) | 1.07 ± 0.21 | 0.78 ± 0.19 | 0.001 |
Postoperatively available data | |||
Histopathologic features | < 0.001 | ||
Hepatocellular carcinoma | |||
Grade 1–2 | 79 | 10 | |
Grade 3–4 | 0 | 3 | |
HCC + I-CC | 1 | 1 | |
HCC + cHCC-CC | 1 | 2 | |
Microvascular invasion | < 0.001 | ||
No | 72 | 7 | |
Yes | 9 | 9 |